![Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection | Antimicrobial Agents and Chemotherapy Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.02273-21/asset/c7aef656-1c7a-4a39-bf66-bee1987117c9/assets/images/large/aac.02273-21-f006.jpg)
Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection | Antimicrobial Agents and Chemotherapy
![Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis](https://mma.prnewswire.com/media/1278645/Micreos_Logo.jpg?p=facebook)
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis
![Gladskin's New Redness Relief Cream, Designed for Facial Redness and Rosacea-Prone Skin, Features First In Category Innovation Gladskin's New Redness Relief Cream, Designed for Facial Redness and Rosacea-Prone Skin, Features First In Category Innovation](https://mma.prnewswire.com/media/1486101/GladSkin_RednessRelief.jpg)
Gladskin's New Redness Relief Cream, Designed for Facial Redness and Rosacea-Prone Skin, Features First In Category Innovation
![New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms](https://mma.prnewswire.com/media/1704248/GLADSKIN_Endolysin_Staphefekt.jpg?w=200)
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis - JDDonline - Journal of Drugs in Dermatology
![SDS-PAGE and zymogram analysis of lysin constructs. (A) Analysis of... | Download Scientific Diagram SDS-PAGE and zymogram analysis of lysin constructs. (A) Analysis of... | Download Scientific Diagram](https://www.researchgate.net/publication/7181784/figure/fig2/AS:281488110178307@1444123403331/SDS-PAGE-and-zymogram-analysis-of-lysin-constructs-A-Analysis-of-endolysin-B30-443-and.png)
SDS-PAGE and zymogram analysis of lysin constructs. (A) Analysis of... | Download Scientific Diagram
![New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms](https://mma.prnewswire.com/media/1704248/GLADSKIN_Endolysin_Staphefekt.jpg?p=facebook)
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
![Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine](https://www.microbiometimes.com/wp-content/uploads/2020/09/shutterstock_1513340948-2-678x381.jpg)
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine
![Introducing Gladskin Eczema Cream with Micreobalance™: A Swiss Scientific Breakthrough that Reduces Eczema Itch and Redness, Moisturizes while Rebalancing the Skin Microbiome in a Smarter and Safe... | Markets Insider Introducing Gladskin Eczema Cream with Micreobalance™: A Swiss Scientific Breakthrough that Reduces Eczema Itch and Redness, Moisturizes while Rebalancing the Skin Microbiome in a Smarter and Safe... | Markets Insider](https://mma.prnewswire.com/media/1062241/Gladskin_Eczema_Cream_with_Micreobalance.jpg)